Aduro Biotech Appoints Sylvia R. Wheeler As Senior Vice President, Corporate Affairs And Investor Relations

Aduro Biotech, Inc. today announced the appointment of Sylvia R. Wheeler to the position of senior vice president, Corporate Affairs and Investor Relations. Ms. Wheeler, a veteran biopharmaceutical executive, joins Aduro with over 20 years of experience driving communications strategies and initiatives. In her new role, Ms. Wheeler will be a member of the executive leadership team and will report to Stephen T. Isaacs, chairman, president and chief executive officer of Aduro.

Suggested Articles

Californian RNA biotech Arrowhead will lose its COO and R&D head from next year but is hiring a new CMO and CSO to help steady its research exec team.

The biotech began testing the small molecule in a phase 3 trial of heavily pretreated small cell lung cancer patients late last year. 

Roche is spending up to $1.4 billion to snap up a scarring-focused biotech, nabbing an FDA breakthrough-tagged therapy in the process.